{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T01:37:48Z","timestamp":1649122668438},"reference-count":13,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.2515\/therapie\/2015044","type":"journal-article","created":{"date-parts":[[2015,8,3]],"date-time":"2015-08-03T06:32:58Z","timestamp":1438583578000},"page":"541-544","source":"Crossref","is-referenced-by-count":1,"title":["Thrombop\u00e9nie s\u00e9v\u00e8re chez une patiente trait\u00e9e par fluvastatine"],"prefix":"10.1016","volume":"70","author":[{"given":"Arnaud","family":"Potier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Dony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline","family":"Crapsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Piney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Dufay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.2515\/therapie\/2015044_bb0950","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1528-1167.2007.01429.x","article-title":"Valproate-induced thrombocytopenia: a prospective monotherapy study","volume":"49","author":"Nasreddine","year":"2008","journal-title":"Epilepsia"},{"key":"10.2515\/therapie\/2015044_bb0955","unstructured":"LESCOL L.P. 80mg, comprim\u00e9 pellicul\u00e9 \u00e0 lib\u00e9ration prolong\u00e9e. Monographie. http:\/\/www.theriaque.org\/apps\/monographie\/index.php?type=SP&id=13943 . 14 mars 2012 Consult\u00e9 le 2 juillet 2015"},{"issue":"6","key":"10.2515\/therapie\/2015044_bb0960","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/09537104.2011.633179","article-title":"French Association of Regional Pharmacovigilance Centers. Drug-induced immune thrombocytopenia: a descriptive survey in the French PharmacoVigilance database","volume":"23","author":"Moulis","year":"2012","journal-title":"Platelets"},{"issue":"9","key":"10.2515\/therapie\/2015044_bb0965","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00277-008-0480-1","article-title":"Simvastatin-induced thrombocytopaenia: a further case and a brief on its clinical relevance","volume":"87","author":"Ames","year":"2008","journal-title":"Ann Hematol"},{"key":"10.2515\/therapie\/2015044_bb0970","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0140-6736(05)70491-8","article-title":"Atorvastatin-induced severe thrombocytopenia","volume":"352","author":"Gonz\u00e1lez-Ponte","year":"1998","journal-title":"Lancet"},{"key":"10.2515\/therapie\/2015044_bb0975","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ajh.1136","article-title":"Simvastatin-induced thrombocytopenia","volume":"67","author":"Groneberg","year":"2001","journal-title":"Am J Hematol"},{"key":"10.2515\/therapie\/2015044_bb0980","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2165\/00044011-199816020-00011","article-title":"Severe thrombocytopaenia caused by simvastatin in which thrombocyte recovery was initiated after severe bacterial infection","volume":"16","author":"Yamada","year":"1998","journal-title":"Clin Drug Investig"},{"key":"10.2515\/therapie\/2015044_bb0985","first-page":"357","article-title":"Thrombocytopenic purpura during therapy with simvastatin","volume":"77","author":"Possamai","year":"1992","journal-title":"Haematologica"},{"issue":"7","key":"10.2515\/therapie\/2015044_bb0990","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/SMJ.0b013e3181e170f5","article-title":"Rosuvastatin-induced thrombocytopenia","volume":"103","author":"Vrettos","year":"2010","journal-title":"South Med J"},{"key":"10.2515\/therapie\/2015044_bb0995","unstructured":"Centre d\u2019informations th\u00e9rapeutique et de pharmacovigilance. Service de pharmacologie et toxicologie cliniques, H\u00f4pitaux Universitaires, 1211 Gen\u00e8ve 14. Interactions m\u00e9dicamenteuses, cytochromes P450 et P-glycoprot\u00e9ine (Pgp). Octobre 2014 http:\/\/pharmacoclin.hug-ge.ch\/_library\/pdf\/cytp450pgp.pdf Consult\u00e9 le 2 juillet 2015 (2 pages)"},{"issue":"3 Suppl","key":"10.2515\/therapie\/2015044_bb1000","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.jacl.2014.02.010","article-title":"The National Lipid Association\u2019s Safety Task Force. A clinician\u2019s guide to statin drug-drug interactions","volume":"8","author":"Kellick","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.2515\/therapie\/2015044_bb1005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.phrs.2013.12.002","article-title":"The pharmacogenomics of statins","volume":"88","author":"Gelissen","year":"2014","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.2515\/therapie\/2015044_bb1010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/toxsci\/kfl096","article-title":"Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1\/*1 genotype","volume":"94","author":"Kiang","year":"2006","journal-title":"Toxicol Sci"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716311015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716311015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T12:03:26Z","timestamp":1554293006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716311015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0040595716311015"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2015044","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}